{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T04:23:08Z","timestamp":1729916588601,"version":"3.28.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03372-8","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T11:01:51Z","timestamp":1726311711000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia"],"prefix":"10.1007","volume":"316","author":[{"given":"Divija","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas A.","family":"Adalsteinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Kristinn","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigr\u00fan","family":"Thorsteinsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saemundur","family":"R\u00f6gnvaldsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1sd\u00eds R","family":"\u00de\u00f3r\u00f0ard\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brynjar","family":"Vi\u00f0arsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e1ll T","family":"\u00d6nundarson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarni A","family":"Agnarssond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margr\u00e9t","family":"Sigur\u00f0ard\u00f3ttird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingunn","family":"\u00deorsteinsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00cdsleifur","family":"\u00d3lafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00edas","family":"Ey\u00fe\u00f3rsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1sbj\u00f6rn","family":"J\u00f3nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andri","family":"\u00d3lafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauti Kjartan","family":"G\u00edslason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Hulcrantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian GM","family":"Durie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorvardur Jon","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurdur Yngvi","family":"Kristinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"3372_CR1","doi-asserted-by":"publisher","first-page":"232470961775273","DOI":"10.1177\/2324709617752737","volume":"6","author":"A Bilal","year":"2018","unstructured":"Bilal A, Der Mesropian P, Lam F, Shaikh G (2018) Oligosecretory Myeloma with amyloidosis and Alopecia. J Investig Med High Impact Case Rep 6:2324709617752737. https:\/\/doi.org\/10.1177\/2324709617752737","journal-title":"J Investig Med High Impact Case Rep"},{"key":"3372_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jdcr.2021.05.041","volume":"15","author":"B Nia","year":"2021","unstructured":"Nia B, Dhaliwal P, Rodney IJ, Lewin MR (2021) A case of plasma cell dyscrasia presenting as nonscarring alopecia. JAAD Case Rep 15:30\u201332. https:\/\/doi.org\/10.1016\/j.jdcr.2021.05.041","journal-title":"JAAD Case Rep"},{"issue":"4","key":"3372_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-022-00661-1","volume":"12","author":"JS Claveau","year":"2022","unstructured":"Claveau JS, Wetter DA, Kumar S (2022) Cutaneous manifestations of monoclonal gammopathy. Blood Cancer J 12(4):58. https:\/\/doi.org\/10.1038\/s41408-022-00661-1","journal-title":"Blood Cancer J"},{"issue":"5","key":"3372_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41408-021-00480-w","volume":"11","author":"S Rognvaldsson","year":"2021","unstructured":"Rognvaldsson S, Love TJ, Thorsteinsdottir S et al (2021) Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J 11(5):94. https:\/\/doi.org\/10.1038\/s41408-021-00480-w","journal-title":"Blood Cancer J"},{"issue":"Supplement 1","key":"3372_CR5","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.1182\/blood-2022-169393","volume":"140","author":"IS Sverrisdottir","year":"2022","unstructured":"Sverrisdottir IS, Thorsteinsd\u00f3ttir S, R\u00f6gnvaldsson S et al (2022) Autoimmune diseases are not associated with monoclonal gammopathy of undetermined significance: results of the prospective population-based Istopmm study. Blood 140(Supplement 1):10031\u201310032","journal-title":"Blood"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03372-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T17:04:18Z","timestamp":1729875858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03372-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":5,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["3372"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03372-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2024,9,14]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BU is an employee of Mount Sinai and has received research funds (grants paid to the institution) from: Arcutis Biotherapeutics, Incyte, Rapt Therapeutics, Pfizer, and Sanofi. He is also a consultant for Arcutis Biotherapeutics, Bristol Myers Squibb, Castle Biosciences, Fresenius Kabi, Galderma, Janssen, Lilly, Pfizer, Primus Pharmaceuticals, Sanofi, and UCB. The other authors have no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The study protocol, all information material, biobank, and questionnaires were approved by the Icelandic National Bioethics Committee (Number 16\u2013022, date: 2016-04-26) with approval from the Icelandic Data Protection Agency.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval"}}],"article-number":"627"}}